Friedman HS - Search Results

1

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.

Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA. Desjardins A, et al. Among authors: friedman hs, friedman ah. J Neurooncol. 2007 May;83(1):53-60. doi: 10.1007/s11060-006-9302-2. Epub 2007 Jan 24. J Neurooncol. 2007. PMID: 17245623 Clinical Trial.

2

Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.

Friedman HS, Dolan ME, Moschel RC, Pegg AE, Felker GM, Rich J, Bigner DD, Schold SC Jr. Friedman HS, et al. J Natl Cancer Inst. 1992 Dec 16;84(24):1926-31. doi: 10.1093/jnci/84.24.1926. J Natl Cancer Inst. 1992. PMID: 1334154

3

Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.

Smith DC, Vick NA, Trump DL, Friedman HS, Friedman AH, Purvis J, Gauspari A, Schold SC Jr. Smith DC, et al. Among authors: friedman hs, friedman ah. Cancer Chemother Pharmacol. 1992;30(4):272-6. doi: 10.1007/BF00686294. Cancer Chemother Pharmacol. 1992. PMID: 1643694 Clinical Trial.

4

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.

Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH Jr, et al. Friedman HS, et al. J Clin Oncol. 1992 Feb;10(2):249-56. doi: 10.1200/JCO.1992.10.2.249. J Clin Oncol. 1992. PMID: 1732426 Clinical Trial.

5

Medulloblastoma: tumor biological and clinical perspectives.

Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD. Friedman HS, et al. J Neurooncol. 1991 Aug;11(1):1-15. doi: 10.1007/BF00166992. J Neurooncol. 1991. PMID: 1919642 Review.

6

Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.

Longee DC, Friedman HS, Albright RE Jr, Burger PC, Oakes WJ, Moore JO, Schold SC Jr. Longee DC, et al. Among authors: friedman hs. J Neurosurg. 1990 Apr;72(4):583-8. doi: 10.3171/jns.1990.72.4.0583. J Neurosurg. 1990. PMID: 2319317

7

Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma.

Friedman HS, Schold SC Jr, Mahaley MS Jr, Colvin OM, Oakes WJ, Vick NA, Burger PC, Bigner SH, Borowitz M, Halperin EC, et al. Friedman HS, et al. J Clin Oncol. 1989 Jul;7(7):904-11. doi: 10.1200/JCO.1989.7.7.904. J Clin Oncol. 1989. PMID: 2738624

8

Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.

Friedman HS, Schold SC Jr, Djang WT, Kurtzberg J, Longee DC, Halperin EC, Falletta JM, Coleman RE, Oakes WJ. Friedman HS, et al. Neurology. 1989 Jan;39(1):62-6. doi: 10.1212/wnl.39.1.62. Neurology. 1989. PMID: 2783351

9

The chemotherapy of posterior fossa tumors in childhood.

Friedman HS, Oakes WJ. Friedman HS, et al. J Neurooncol. 1987;5(3):217-29. doi: 10.1007/BF00151225. J Neurooncol. 1987. PMID: 3316521 Review.

10

Recurrent brain tumors in children.

Friedman HS, Oakes WJ. Friedman HS, et al. Pediatr Neurosci. 1987;13(5):233-41. doi: 10.1159/000120336. Pediatr Neurosci. 1987. PMID: 3332817 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters